SUPRACHOROIDAL INTERNAL DEVELOPMENT PIPELINE
STUDY DRUG
INDICATION
CURRENT STATUS
STUDY DRUG, INDICATION, CURRENT STATUS
COMMERCIAL COLLABORATIONS
PARTNER
LICENSED TERRITORY
CURRENT STATUS
PARTNER, INDICATION, CURRENT STATUS
Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand
Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand
DEVELOPMENT AND COMMERCIAL COLLABORATIONS USING SCS MICROINJECTOR®
